Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipitor in the Treatment of Alzheimer's Disease
NCT00024531Phase 2Completed
- Sponsor
- Alzheimer's Drug Discovery Foundation
- Start
- Oct 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing Atorvastatin calcium with Placebo (2 arms). Primary endpoint: Neuropsychological testing at 12 months. Started Oct 2000; status: completed.
02
Drugs
atorvastatin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00024531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00024531.